In This Section

CRI, ENCI, and AACR to Present the International Cancer Immunotherapy Conference in New York, Sept. 28-Oct. 1, 2022

July 27, 2022

NEW YORK – The Cancer Research Institute (CRI), the European Network for Cancer Immunotherapy (ENCI), and the American Association for Cancer Research (AACR) will present the sixth International Cancer Immunotherapy Conference (CICON) at the New York Hilton Midtown in New York City, Sept. 28-Oct. 1, 2022. This conference is an in-person event and will not be live streamed or recorded for virtual participation. Registration for this meeting is complimentary for credentialed members of the media. Proof of COVID-19 vaccination will be required.

The program will focus on “Translating Science into Survival” and feature talks from more than 60 leaders in the field covering all areas of inquiry in cancer immunology and immunotherapy, including T-cell failure in immunotherapy; understanding the tumor microenvironment and its impact on antitumor response; cellular therapies; tumor vaccination, and much more.

View the meeting program.

MEDIA REGISTRATION

To register, journalists must provide:

  • Official press credentials such as a business card, editorial roster or masthead, international press card, or letter of assignment
  • Bylined coverage from a previous CICON or AACR meeting. First-time attendees must provide two examples of recent bylined health/medical/science coverage in news outlets that meet the organizers’ criteria
  • Freelance journalists who have a letter of assignment should upload a copy of the letter to the registration form linked below
  • Members of the Association of Health Care Journalists (AHCJ) may register regardless of assignment and should upload proof of membership to the registration form linked below

Please review the full media registration requirements and policies. Journalists can request registration by filling out this form. Contact Kathleen Venango at [email protected] or 215-290-5408 with registration questions.

CONTACT

For more information, contact a member of the AACR public relations team: